{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T23:24:41Z","timestamp":1790897081787,"version":"4.1.0"},"reference-count":79,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Advances in Chronic Kidney Disease"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1053\/j.ackd.2010.01.001","type":"journal-article","created":{"date-parts":[[2010,2,27]],"date-time":"2010-02-27T04:31:15Z","timestamp":1267245075000},"page":"153-163","source":"Crossref","is-referenced-by-count":162,"title":["Hypertension in Autosomal Dominant Polycystic Kidney Disease"],"prefix":"10.1053","volume":"17","author":[{"given":"Arlene B.","family":"Chapman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konrad","family":"Stepniakowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederic","family":"Rahbari-Oskoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.ackd.2010.01.001_bib1","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1056\/NEJM199307293290508","article-title":"Autosomal dominant polycystic kidney disease","volume":"329","author":"Gabow","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1053\/j.ackd.2010.01.001_bib2","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/ki.2009.128","article-title":"Autosomal dominant polycystic kidney disease: The last 3 years","volume":"76","author":"Torres","year":"2009","journal-title":"Kidney Int"},{"key":"10.1053\/j.ackd.2010.01.001_bib3","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.2215\/CJN.00060108","article-title":"Approaches to testing new treatments in autosomal dominant polycystic kidney disease: Insights from the CRISP and HALT-PKD studies","volume":"3","author":"Chapman","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1053\/j.ackd.2010.01.001_bib4","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1053\/ajkd.2001.27720","article-title":"Survival after end-stage renal disease in autosomal dominant polycystic kidney disease: Contribution of extrarenal complications to mortality","volume":"38","author":"Perrone","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ackd.2010.01.001_bib5","first-page":"806","article-title":"Analysis of causes of mortality in patients with autosomal dominant polycystic kidney disease: A single center study","volume":"20","author":"Rahman","year":"2009","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"10.1053\/j.ackd.2010.01.001_bib6","doi-asserted-by":"crossref","first-page":"c158","DOI":"10.1159\/000256568","article-title":"Comparison of intracerebral hemorrhage and subarachnoid hemorrhage in patients with autosomal-dominant polycystic kidney disease","volume":"114","author":"Chang","year":"2009","journal-title":"Nephron Clin Pract"},{"key":"10.1053\/j.ackd.2010.01.001_bib7","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1046\/j.1523-1755.2003.00185.x","article-title":"Renal structure in early autosomal-dominant polycystic kidney disease (ADPKD): The Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) cohort","volume":"64","author":"Chapman","year":"2003","journal-title":"Kidney Int"},{"key":"10.1053\/j.ackd.2010.01.001_bib8","first-page":"S71","article-title":"Hypertension in autosomal dominant polycystic kidney disease","volume":"61","author":"Chapman","year":"1997","journal-title":"Kidney Int Suppl"},{"key":"10.1053\/j.ackd.2010.01.001_bib9","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1681\/ASN.2008080882","article-title":"Renal volume, renin-angiotensin-aldosterone system, hypertension, and left ventricular hypertrophy in patients with autosomal dominant polycystic kidney disease","volume":"20","author":"Schrier","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ackd.2010.01.001_bib10","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/S0272-6386(83)80044-4","article-title":"Epidemiology of adult polycystic kidney disease, Olmsted County, Minnesota: 1935-1980","volume":"2","author":"Iglesias","year":"1983","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ackd.2010.01.001_bib11","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1038\/ki.1992.195","article-title":"Factors affecting the progression of renal disease in autosomal-dominant polycystic kidney disease","volume":"41","author":"Gabow","year":"1992","journal-title":"Kidney Int"},{"key":"10.1053\/j.ackd.2010.01.001_bib12","doi-asserted-by":"crossref","first-page":"12174","DOI":"10.1073\/pnas.211191098","article-title":"Cardiovascular, skeletal, and renal defects in mice with a targeted disruption of the Pkd1 gene","volume":"98","author":"Boulter","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.ackd.2010.01.001_bib13","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/71724","article-title":"Cardiac defects and renal failure in mice with targeted mutations in Pkd2","volume":"24","author":"Wu","year":"2000","journal-title":"Nat Genet"},{"key":"10.1053\/j.ackd.2010.01.001_bib14","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0092-8674(03)00511-7","article-title":"Two populations of node monocilia initiate left-right asymmetry in the mouse","volume":"114","author":"McGrath","year":"2003","journal-title":"Cell"},{"key":"10.1053\/j.ackd.2010.01.001_bib15","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1073\/pnas.040550097","article-title":"Polycystin 1 is required for the structural integrity of blood vessels","volume":"97","author":"Kim","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.ackd.2010.01.001_bib16","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.1093\/hmg\/ddh336","article-title":"Lowering of Pkd1 expression is sufficient to cause polycystic kidney disease","volume":"13","author":"Lantinga-van Leeuwen","year":"2004","journal-title":"Hum Mol Genet"},{"key":"10.1053\/j.ackd.2010.01.001_bib17","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/ng1097-179","article-title":"Perinatal lethality with kidney and pancreas defects in mice with a targetted Pkd1 mutation","volume":"17","author":"Lu","year":"1997","journal-title":"Nat Genet"},{"key":"10.1053\/j.ackd.2010.01.001_bib18","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/S0960-9822(02)00869-2","article-title":"The ion channel polycystin-2 is required for left right axis determination in mice","volume":"4","author":"Pennekamp","year":"2002","journal-title":"Curr Biol"},{"key":"10.1053\/j.ackd.2010.01.001_bib19","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1161\/ATVBAHA.107.149252","article-title":"Pathogenic sequence for dissecting aneurysm formation in a hypomorphic polycystic kidney disease 1 mouse model","volume":"27","author":"Hassane","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1053\/j.ackd.2010.01.001_bib20","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1097\/01.ASN.0000080185.38113.A3","article-title":"Analysis of the polycystins in aortic vascular smooth muscle cells","volume":"14","author":"Qian","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ackd.2010.01.001_bib21","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1093\/hmg\/ddg190","article-title":"Pkd2 haploinsufficiency alters intracellular calcium regulation in vascular smooth muscle cells","volume":"12","author":"Qian","year":"2003","journal-title":"Hum Mol Genet"},{"key":"10.1053\/j.ackd.2010.01.001_bib22","doi-asserted-by":"crossref","first-page":"14225","DOI":"10.1074\/jbc.M312223200","article-title":"Drosophila Pkd2 is haploid-insufficient for mediating optimal smooth muscle contractility","volume":"279","author":"Gao","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1053\/j.ackd.2010.01.001_bib23","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1161\/CIRCULATIONAHA.107.710111","article-title":"Endothelial cilia are fluid shear sensors that regulate calcium signaling and nitric oxide production through polycystin-1","volume":"117","author":"Nauli","year":"2008","journal-title":"Circulation"},{"key":"10.1053\/j.ackd.2010.01.001_bib24","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1161\/CIRCRESAHA.108.192765","article-title":"Ciliary polycystin-2 is a mechanosensitive calcium channel involved in nitric oxide signaling cascades","volume":"104","author":"Abou Alaiwi","year":"2009","journal-title":"Circ Res"},{"key":"10.1053\/j.ackd.2010.01.001_bib25","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1046\/j.1523-1755.2001.0590051654.x","article-title":"Progression of autosomal-dominant polycystic kidney disease in children","volume":"59","author":"Fick-Brosnahan","year":"2001","journal-title":"Kidney Int"},{"key":"10.1053\/j.ackd.2010.01.001_bib26","doi-asserted-by":"crossref","first-page":"560","DOI":"10.2215\/CJN.02410508","article-title":"Quality of life in autosomal dominant polycystic kidney disease patients not yet on dialysis","volume":"4","author":"Rizk","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1053\/j.ackd.2010.01.001_bib27","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1681\/ASN.V5122032","article-title":"Cardiovascular abnormalities in children with autosomal dominant polycystic kidney disease","volume":"5","author":"Ivy","year":"1995","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ackd.2010.01.001_bib28","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1038\/ki.2008.397","article-title":"Increased left ventricular mass in children with autosomal dominant polycystic kidney disease and borderline hypertension","volume":"74","author":"Cadnapaphornchai","year":"2008","journal-title":"Kidney Int"},{"key":"10.1053\/j.ackd.2010.01.001_bib29","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/00126097-200306000-00003","article-title":"Ambulatory blood pressure correlates with renal volume and number of renal cysts in children with autosomal dominant polycystic kidney disease","volume":"8","author":"Seeman","year":"2003","journal-title":"Blood Press Monit"},{"key":"10.1053\/j.ackd.2010.01.001_bib30","first-page":"629","article-title":"Renal concentrating capacity is linked to blood pressure in children with autosomal dominant polycystic kidney disease","volume":"53","author":"Seeman","year":"2004","journal-title":"Physiol Res"},{"key":"10.1053\/j.ackd.2010.01.001_bib31","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.2215\/CJN.05281107","article-title":"Role of vasopressin antagonists","volume":"3","author":"Torres","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1053\/j.ackd.2010.01.001_bib32","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1097\/01.hjh.0000222765.30348.0d","article-title":"The effect of sodium and angiotensin-converting enzyme inhibition on the classic circulating renin-angiotensin system in autosomal-dominant polycystic kidney disease patients","volume":"24","author":"Doulton","year":"2006","journal-title":"J Hypertens"},{"key":"10.1053\/j.ackd.2010.01.001_bib33","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1681\/ASN.V881292","article-title":"Left ventricular hypertrophy in autosomal dominant polycystic kidney disease","volume":"8","author":"Chapman","year":"1997","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ackd.2010.01.001_bib34","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1681\/ASN.V1051020","article-title":"Ambulatory blood pressure and left ventricular mass in normotensive patients with autosomal dominant polycystic kidney disease","volume":"10","author":"Valero","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ackd.2010.01.001_bib35","doi-asserted-by":"crossref","first-page":"986","DOI":"10.2215\/CJN.02330607","article-title":"Coronary flow velocity reserve and carotid intima media thickness in patients with autosomal dominant polycystic kidney disease: From impaired tubules to impaired carotid and coronary arteries","volume":"3","author":"Turkmen","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1053\/j.ackd.2010.01.001_bib36","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/nrneph.2009.13","article-title":"Cardiovascular abnormalities in autosomal-dominant polycystic kidney disease","volume":"5","author":"Ecder","year":"2009","journal-title":"Nat Rev Nephrol"},{"key":"10.1053\/j.ackd.2010.01.001_bib37","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1053\/j.ajkd.2004.04.026","article-title":"Exercise blood pressure, cardiac structure, and diastolic function in young normotensive patients with polycystic kidney disease: A prehypertensive state","volume":"44","author":"Martinez-Vea","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ackd.2010.01.001_bib38","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1093\/ndt\/gfp136","article-title":"Early renal and vascular changes in ADPKD patients with low-grade albumin excretion and normal renal function","volume":"24","author":"Azurmendi","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.ackd.2010.01.001_bib39","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1053\/j.ajkd.2004.01.011","article-title":"Endothelial dysfunction and increased carotid intima-media thickness in patients with autosomal dominant polycystic kidney disease","volume":"43","author":"Kocaman","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ackd.2010.01.001_bib40","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1440-1797.2008.01049.x","article-title":"Carotid vascular remodelling in patients with autosomal dominant polycystic kidney disease","volume":"14","author":"Rong","year":"2009","journal-title":"Nephrology (Carlton)"},{"key":"10.1053\/j.ackd.2010.01.001_bib41","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1046\/j.1523-1755.2003.00236.x","article-title":"Endothelial dysfunction and reduced nitric oxide in resistance arteries in autosomal-dominant polycystic kidney disease","volume":"64","author":"Wang","year":"2003","journal-title":"Kidney Int"},{"key":"10.1053\/j.ackd.2010.01.001_bib42","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1080\/08860220701641728","article-title":"Ambulatory blood pressure and endothelial dysfunction in patients with autosomal dominant polycystic kidney disease","volume":"29","author":"Turgut","year":"2007","journal-title":"Ren Fail"},{"key":"10.1053\/j.ackd.2010.01.001_bib43","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1681\/ASN.V1181371","article-title":"Endothelium-dependent relaxation of small resistance vessels is impaired in patients with autosomal dominant polycystic kidney disease","volume":"11","author":"Wang","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ackd.2010.01.001_bib44","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-2369-8-13","article-title":"Clinical proof-of-concept trial to assess the therapeutic effect of sirolimus in patients with autosomal dominant polycystic kidney disease: SUISSE ADPKD study","volume":"8","author":"Serra","year":"2007","journal-title":"BMC Nephrol"},{"key":"10.1053\/j.ackd.2010.01.001_bib45","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1046\/j.1523-1755.2003.00264.x","article-title":"The role of parental hypertension in the frequency and age of diagnosis of hypertension in offspring with autosomal-dominant polycystic kidney disease","volume":"64","author":"Schrier","year":"2003","journal-title":"Kidney Int"},{"key":"10.1053\/j.ackd.2010.01.001_bib46","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1097\/00041552-199509000-00016","article-title":"Hypertension in autosomal dominant polycystic kidney disease","volume":"4","author":"Parfrey","year":"1995","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1053\/j.ackd.2010.01.001_bib47","doi-asserted-by":"crossref","first-page":"102","DOI":"10.2215\/CJN.04310709","article-title":"The HALT Polycystic Kidney Disease Trials-Design and Implementation","volume":"5","author":"Chapman","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1053\/j.ackd.2010.01.001_bib48","first-page":"122A","article-title":"Reproducibility of ambulatory blood pressure monitoring (ABPM) in hypertensive (HBP) autosomal dominant polycystic kidney disease (ADPKD)","volume":"19","author":"Rahbari-Oskoui","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ackd.2010.01.001_bib49","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1097\/01.ASN.0000018407.60002.B9","article-title":"Cardiac and renal effects of standard versus rigorous blood pressure control in autosomal-dominant polycystic kidney disease: Results of a seven-year prospective randomized study","volume":"13","author":"Schrier","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ackd.2010.01.001_bib50","first-page":"595","article-title":"The relation of hypertension, renal function and cardiovascular events in autosomal dominant polycystic kidney disease","volume":"24","author":"Idrizi","year":"2007","journal-title":"G Ital Nefrol"},{"key":"10.1053\/j.ackd.2010.01.001_bib51","doi-asserted-by":"crossref","first-page":"c71","DOI":"10.1159\/000228537","article-title":"Cutaneous microcirculation is impaired in early autosomal dominant polycystic kidney disease","volume":"113","author":"Ramunni","year":"2009","journal-title":"Nephron Clin Pract"},{"key":"10.1053\/j.ackd.2010.01.001_bib52","first-page":"497","article-title":"The reproucibility of the circadian BP rhythm in treated hypertensive patients with polycystic kidney disease and mild chronic renal impairment\u2014A prospective ABPM study","volume":"15","author":"Covic","year":"2002","journal-title":"J Nephrol"},{"key":"10.1053\/j.ackd.2010.01.001_bib53","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1159\/000013583","article-title":"Left ventricular hypertrophy in hypertensive patients with autosomal dominant polycystic kidney disease: Influence of blood pressure and humoral and neurohormonal factors","volume":"20","author":"Martinez-Vea","year":"2000","journal-title":"Am J Nephrol"},{"key":"10.1053\/j.ackd.2010.01.001_bib54","first-page":"211","article-title":"Cardiac involvement in autosomal-dominant polycystic kidney disease: A hypertensive heart disease","volume":"56","author":"Bardaji","year":"2001","journal-title":"Clin Nephrol"},{"key":"10.1053\/j.ackd.2010.01.001_bib55","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0272-6386(96)90357-1","article-title":"Prevalent left ventricular hypertrophy in the predialysis population: Identifying opportunities for intervention","volume":"27","author":"Levin","year":"1996","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ackd.2010.01.001_bib56","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1053\/ajkd.2001.29216","article-title":"Mitral valve prolapse and mitral regurgitation are common in patients with polycystic kidney disease type 1","volume":"38","author":"Lumiaho","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ackd.2010.01.001_bib57","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/S0272-6386(03)00354-8","article-title":"Insulin resistance is related to left ventricular hypertrophy in patients with polycystic kidney disease type 1","volume":"41","author":"Lumiaho","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ackd.2010.01.001_bib58","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1053\/ajkd.2002.33379","article-title":"Relationship between renal volume growth and renal function in autosomal dominant polycystic kidney disease: A longitudinal study","volume":"39","author":"Fick-Brosnahan","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ackd.2010.01.001_bib59","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1681\/ASN.V561349","article-title":"Overt proteinuria and microalbuminuria in autosomal dominant polycystic kidney disease","volume":"5","author":"Chapman","year":"1994","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ackd.2010.01.001_bib60","doi-asserted-by":"crossref","first-page":"148","DOI":"10.2215\/CJN.00330705","article-title":"Volume progression in autosomal dominant polycystic kidney disease: The major factor determining clinical outcomes","volume":"1","author":"Grantham","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1053\/j.ackd.2010.01.001_bib61","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1056\/NEJM199010183231602","article-title":"The renin-angiotensin-aldosterone system and autosomal dominant polycystic kidney disease","volume":"323","author":"Chapman","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1053\/j.ackd.2010.01.001_bib62","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1046\/j.1442-2042.2001.00259.x","article-title":"Assessment of renal function with color Doppler ultrasound in autosomal dominant polycystic kidney disease","volume":"8","author":"Kondo","year":"2001","journal-title":"Int J Urol"},{"key":"10.1053\/j.ackd.2010.01.001_bib63","doi-asserted-by":"crossref","first-page":"112","DOI":"10.2215\/CJN.00910306","article-title":"Magnetic resonance measurements of renal blood flow and disease progression in autosomal dominant polycystic kidney disease","volume":"2","author":"Torres","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1053\/j.ackd.2010.01.001_bib64","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/ki.1988.115","article-title":"The anatomy of the renin-secreting cell in adult polycystic kidney disease","volume":"33","author":"Graham","year":"1988","journal-title":"Kidney Int"},{"key":"10.1053\/j.ackd.2010.01.001_bib65","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/S0025-6196(12)61724-8","article-title":"Effect of inhibition of converting enzyme on renal hemodynamics and sodium management in polycystic kidney disease","volume":"66","author":"Torres","year":"1991","journal-title":"Mayo Clin Proc"},{"key":"10.1053\/j.ackd.2010.01.001_bib66","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/ki.1992.28","article-title":"Effects of angiotensin converting enzyme inhibition in adult polycystic kidney disease","volume":"41","author":"Watson","year":"1992","journal-title":"Kidney Int"},{"key":"10.1053\/j.ackd.2010.01.001_bib67","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1159\/000046231","article-title":"Diuretics versus angiotensin-converting enzyme inhibitors in autosomal dominant polycystic kidney disease","volume":"21","author":"Ecder","year":"2001","journal-title":"Am J Nephrol"},{"key":"10.1053\/j.ackd.2010.01.001_bib68","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1097\/00004872-199715090-00002","article-title":"The pathogenesis of hypertension in autosomal dominant polycystic kidney disease","volume":"15","author":"Wang","year":"1997","journal-title":"J Hypertens"},{"key":"10.1053\/j.ackd.2010.01.001_bib69","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/ki.1992.297","article-title":"Synthesis of renin by tubulocystic epithelium in autosomal-dominant polycystic kidney disease","volume":"42","author":"Torres","year":"1992","journal-title":"Kidney Int"},{"key":"10.1053\/j.ackd.2010.01.001_bib70","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1053\/j.ajkd.2007.09.020","article-title":"Asymmetric dimethylarginine and lipid peroxidation products in early autosomal dominant polycystic kidney disease","volume":"51","author":"Wang","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ackd.2010.01.001_bib71","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/01.ASN.0000109782.28991.26","article-title":"Chymase-like angiotensin II-generating activity in end-stage human autosomal dominant polycystic kidney disease","volume":"15","author":"McPherson","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ackd.2010.01.001_bib72","first-page":"507a","volume":"13","author":"Stepniakowski","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ackd.2010.01.001_bib73","first-page":"508a","article-title":"Basal systemic, adrenal and renal responses to angiotensin converting enzyme inhibitor (Enalapril (En) 20 20 mg), angiotensin receptor blocker (Losartan (Los) 50 mg) vs. combination therapy in autosomal dominant polycystic kidney disease (PKD)","volume":"13","author":"Stepniakowski","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ackd.2010.01.001_bib74","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1056\/NEJM199604113341502","article-title":"Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group","volume":"334","author":"Maschio","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1053\/j.ackd.2010.01.001_bib75","doi-asserted-by":"crossref","unstructured":"Klahr, S, Breyer, JA, Beck GJ, et al: Dietary protein restriction, blood pressure control and the progression of polycystic kidney disease. Modification of Diet in Renal Disease Study Group. J Am Soc Nephrol 5:2037-2047, 1995","DOI":"10.1681\/ASN.V5122037"},{"key":"10.1053\/j.ackd.2010.01.001_bib76","doi-asserted-by":"crossref","first-page":"c18","DOI":"10.1159\/000081790","article-title":"Calcium channel blocker versus angiotensin II receptor blocker in autosomal dominant polycystic kidney disease","volume":"99","author":"Nutahara","year":"2005","journal-title":"Nephron Clin Pract"},{"key":"10.1053\/j.ackd.2010.01.001_bib77","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1523-1755.2005.00077.x","article-title":"The effect of angiotensin-converting enzyme inhibitors on progression of polycystic kidney disease (PKD)","volume":"6","author":"Jafar","year":"2005","journal-title":"Kidney Int"},{"key":"10.1053\/j.ackd.2010.01.001_bib78","first-page":"497A","article-title":"Achievement and Maintenance of Blood Pressure Targets in HALT-PKD","volume":"20","author":"Torres","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ackd.2010.01.001_bib79","first-page":"499A","article-title":"HALT-PKD clinical trials, baseline parameters","volume":"20","author":"Torres","year":"2009","journal-title":"J Am Soc Nephrol"}],"container-title":["Advances in Chronic Kidney Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1548559510000029?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1548559510000029?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,10,24]],"date-time":"2021-10-24T00:19:54Z","timestamp":1635034794000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1548559510000029"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":79,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["S1548559510000029"],"URL":"https:\/\/doi.org\/10.1053\/j.ackd.2010.01.001","relation":{},"ISSN":["1548-5595"],"issn-type":[{"value":"1548-5595","type":"print"}],"subject":[],"published":{"date-parts":[[2010,3]]}}}